|
|
|
Insider
Information: |
Stamoulis Christiana |
Relationship: |
EVP & Chief Financial ... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
176,167 |
|
Indirect Shares
|
939 |
|
|
Direct
Value |
$28,353,517 |
|
|
Indirect Value
|
$453,575 |
|
|
Total
Shares |
177,106 |
|
|
Total
Value |
$28,807,092 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Corp Strategy & B... |
2013-07-15 |
40,712 |
2013-07-15 |
939 |
Premium* |
|
Hologic Inc |
HOLX |
Director |
2024-03-07 |
45,472 |
2011-11-01 |
0 |
Premium* |
|
Incyte Corp |
INCY |
EVP & Chief Financial ... |
2024-02-14 |
89,983 |
2019-02-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2011-02-03 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
23,813 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2011-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,445 |
11,445 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2012-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,997 |
16,442 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2013-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,372 |
20,814 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-02-05 |
4 |
A |
$0.01 |
$102 |
D/D |
10,166 |
45,712 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-04-29 |
4 |
OE |
$33.82 |
$2,687,144 |
D/D |
77,999 |
123,711 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-04-29 |
4 |
AS |
$79.08 |
$6,598,756 |
D/D |
(82,999) |
40,712 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-04-30 |
4 |
OE |
$34.57 |
$35 |
D/D |
1 |
40,713 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-04-30 |
4 |
AS |
$77.88 |
$78 |
D/D |
(1) |
40,712 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-05-15 |
4 |
AS |
$79.48 |
$47,949 |
D/D |
(602) |
40,712 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-07-05 |
4 |
AS |
$80.65 |
$380,615 |
D/D |
(4,687) |
40,712 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-07-05 |
4 |
OE |
$34.57 |
$162,030 |
D/D |
4,687 |
45,399 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-07-15 |
4 |
OE |
$33.82 |
$38,048 |
D/D |
1,125 |
41,837 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Strategy & Bus Devlp |
|
2013-07-15 |
4 |
AS |
$86.25 |
$97,139 |
D/D |
(1,125) |
40,712 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2015-01-01 |
4 |
OE |
$26.74 |
$104,660 |
D/D |
3,914 |
24,728 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2016-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,272 |
28,000 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2017-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,427 |
32,633 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2017-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,206 |
30,206 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,406 |
35,039 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-10-02 |
4 |
OE |
$15.29 |
$473,485 |
D/D |
30,967 |
66,006 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-10-02 |
4 |
AS |
$40.70 |
$1,260,481 |
D/D |
(30,967) |
35,039 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-11-28 |
4 |
OE |
$17.51 |
$232,130 |
D/D |
13,257 |
48,296 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2018-11-28 |
4 |
AS |
$44.50 |
$589,950 |
D/D |
(13,257) |
35,039 |
0 |
- |
|
INCY |
Incyte Corp |
EVP & Chief Financial Officer |
|
2019-02-11 |
4 |
A |
$80.21 |
$824,960 |
D/D |
10,285 |
10,285 |
0 |
- |
|
HOLX |
Hologic Inc |
Director |
|
2019-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,136 |
37,175 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|